Shares of Grail, Inc. (NASDAQ:GRAL – Get Free Report) saw an uptick in trading volume on Tuesday . 945,734 shares traded hands during mid-day trading, a decline of 26% from the previous session’s volume of 1,280,710 shares.The stock last traded at $61.89 and had previously closed at $55.02.
Analyst Ratings Changes
Several brokerages have commented on GRAL. Morgan Stanley began coverage on shares of Grail in a report on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 price objective for the company. Wolfe Research began coverage on shares of Grail in a report on Friday, November 15th. They issued a “peer perform” rating for the company.
Get Our Latest Stock Report on Grail
Grail Price Performance
Grail (NASDAQ:GRAL – Get Free Report) last issued its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, topping the consensus estimate of ($4.41) by $2.55. On average, sell-side analysts predict that Grail, Inc. will post -65.16 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of GRAL. Crcm LP bought a new position in shares of Grail in the 4th quarter worth about $65,061,000. Sessa Capital IM L.P. bought a new stake in Grail during the 4th quarter valued at about $53,550,000. Primecap Management Co. CA bought a new stake in Grail during the 4th quarter valued at about $37,118,000. Baker BROS. Advisors LP bought a new stake in Grail during the 4th quarter valued at about $29,098,000. Finally, Vanguard Group Inc. bought a new stake in Grail during the 4th quarter valued at about $25,902,000.
About Grail
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
See Also
- Five stocks we like better than Grail
- Breakout Stocks: What They Are and How to Identify Them
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Grail Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grail and related companies with MarketBeat.com's FREE daily email newsletter.